SCYX
SCYNEXIS, Inc.
NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS
Rating:C-
Company Profile
CEO
David Gonzalez Angulo
IPO Date
2014-05-02
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
SCYNEXIS, Inc.
CEO
David Gonzalez Angulo
IPO Date
2014-05-02
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US